Why the study?
Does a 12-week supervised endurance training program reduce circulating ADMA and MPO levels in persons at elevated cardiovascular risk?
Population
48 subjects with elevated cardiovascular risk, including 10 patients with coronary artery disease, age 31-68…
Comparison
Supervised 12-week endurance training. vs Matched inactive control group.
Design
Cohort
Follow-up
12 weeks
Authors
Loading...
Endurance training-associated ADMA/MPO reductions in elevated-risk patients are hypothesis-generating; prospective RCTs needed before clinical adoption.
Does a 12-week supervised endurance training program reduce circulating ADMA and MPO levels in persons at elevated cardiovascular risk?
A 12-week supervised endurance training program significantly reduces circulating levels of the cardiovascular risk markers ADMA and MPO in patients at elevated risk for coronary events.
Penka et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: